Clinical Trial Update: Plinabulin vs. Pegfilgrastim in Prevention of TAC Induced Neutropenia [Phase 3]

View source ↗

Summary

Phase 3 trial update comparing plinabulin to pegfilgrastim for prevention of TAC-induced neutropenia in chemotherapy patients; current status unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Neutropenia

Drugs mentioned

• Pegfilgrastim (pegfilgrastim)
• Plinabulin (plinabulin)

Snippet

Sponsor: BeyondSpring Pharmaceuticals Inc. | Conditions: Chemotherapy-induced Neutropenia | Phase 3 | Status: UNKNOWN